2Long R,Manfreda J,Mendella L,Wolfe J,Parker S,Hershfield E.Antituberculous drug resistance in Manitoba from 1980 to 1989. Canadian Medical Association Journal . 1993
3Nunn P P,Mungai M,Nyamwaya J et al.The effect of human immunodeficiency virus type 1 on the infectionsness of tuberculosis. Tubercle and Lung Disease . 1994
4Rubel A,Garro L.Social and cultural factors in the successful control of tuberculosis. Public Health Reviews . 1992
5Chawla,PK,Klapper,PJ,Kamholz,SL,Pollack,AH,Henrich,AE.Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. American Review . 1992
6Mitchison D,Nunn A.Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. The American Review of Respiratory Disease . 1986
7Centers for Disease Control.Transmission of multidrug-resistant tuberculosis from an HIV--positive client in a residential substance-abuse treatment facility-Michigan. Morbidity and Mortality Weekly Report . 1991
8Centres for Disease Control.Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital-Florida. Morbidity and Mortality Weekly Report . 1990
9Dooley S W,Villarino M E,Lawrence M et al.Nosocomial transmission of tuberculosis in a hospital unit for HIV--infected patients. The Journal of The American Medical Association . 1992
10Pitchenik A E,Burr J,Laufer M et al.Outbreaks of drug-resis tant tuberculosis at AIDS centre. The Lancet . 1990
8Crofton J,Chaulet P,Maher D.Guidelines on the managementof drug-resistant tuberculosis.Geneva:World HealthOrganization,1997.
9Stang A.Critical evaluation of the Newcastle-Ottawa scale forthe assessment of the quality of nonrandomized studies inmeta-analyses[J].Eur J Epidemiol,2010,25(9):603-605.
10Guyatt GH,Oxman AD,Vist GE,et al.GRADE:an emergingconsensus on rating quality of evidence and strength ofrecommendations[J].BMJ,2008,336:924-926.
